Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Curtiss-Wright Corporation (NYSE: CW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Curtiss-Wright is a global integrated business that supplies highly engineered products, solutions and services mainly to aerospace and defense markets, and critical technologies in commercial nuclear power, process and industrial markets. Its filings offer detailed insight into how these activities translate into financial results, risks and capital allocation decisions.
Through periodic reports such as Form 10-K and Form 10-Q, Curtiss-Wright presents segment information for Aerospace & Industrial, Defense Electronics, and Naval & Power, along with discussions of total aerospace and defense markets and total commercial markets. These documents typically include data on sales, operating income, operating margin, new orders, backlog and free cash flow, as well as commentary on factors such as product mix, restructuring initiatives and operational excellence programs.
Current reports on Form 8-K provide updates on specific events, including quarterly and annual earnings releases, changes to financial guidance, adoption of Rule 10b5-1 trading plans for share repurchases, and expansions of repurchase authorizations. These filings describe how Curtiss-Wright structures its repurchase programs, the amounts authorized, and the expected timing of purchases under those plans.
Stock Titan enhances access to these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand segment performance, capital allocation actions and notable risk disclosures. Real-time updates from EDGAR, along with visibility into relevant forms such as 10-K, 10-Q and 8-K, allow investors and researchers to review Curtiss-Wright’s regulatory history and ongoing reporting in a structured, easy-to-navigate format.
A holder of 435 shares of common stock has filed a notice of proposed sale under Rule 144. The shares were acquired through a performance stock vest from the issuer on 02/03/2026 and are to be sold through UBS Financial Services Inc.
The filing lists an aggregate market value of 272,427.46 for these shares, with an approximate sale date of 02/03/2026 on the NYSE. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
John Watts filed a Rule 144 notice to sell 652 common shares of CW. The planned sale, through UBS Financial Services Inc. on the NYSE, has an aggregate market value of $407,748.55, with 36,874,638 shares of this class outstanding.
The 652 shares were acquired on 02/03/2026 via a performance stock vest from the issuer. Over the prior three months, John Watts sold additional CW common shares in several transactions totaling 688 shares, with reported gross proceeds ranging from $61,935 to $172,800 per transaction.
A holder of common shares of CW has filed a Rule 144 notice to sell 2,634 shares through UBS Financial Services on the NYSE, with an aggregate market value of
Curtiss-Wright executive K. Christopher Farkas filed a Rule 144 notice to sell 2,665 shares of common stock, with an aggregate market value of $1,669,034.61, through UBS Financial Services on or about February 4, 2026 on the NYSE.
The 2,665 shares were acquired on February 3, 2026 via a performance stock vest from the issuer. Curtiss-Wright had 36,874,638 shares outstanding of this class. In the prior three months, Farkas sold 5,047 common shares on November 11, 2025 for gross proceeds of $2,916,463.
Curtiss-Wright Corporation has a shareholder filing a Rule 144 notice covering the planned sale of 418 shares of common stock, with an aggregate market value of
Lynn Bamford has filed a notice of proposed sale under Rule 144 to sell 9,327 shares of CW common stock through UBS Financial Services Inc. on or about 02/04/2026 on the NYSE, with an aggregate market value listed as 5842467.3 and 36,874,638 shares outstanding.
The 9,327 shares were acquired on 02/03/2026 via a performance stock vest from the issuer, with payment dated the same day and described as n/a. The notice also discloses two prior sales in the past three months, each for 3,750 common shares, with gross proceeds of 2058815 and 2166513.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring common stock through the company’s 2024 Omnibus Incentive Plan. On January 20, 2026, he acquired 218 shares of common stock at a reference price of $660.66 per share, bringing his directly held stake to 12,647 shares.
The footnotes explain that these shares relate to director compensation earned in 2024, including a portion of his annual restricted stock award, annual retainer, and meeting fees that he elected to receive in stock. Receipt of this portion, equal to 20% of the total annual restricted stock award, retainer, and fees, was deferred and is being paid in five equal annual installments beginning January 15, 2026. The number of shares is based on the closing market prices on the dates the award and fees were approved or earned and includes rounded amounts and dividend credits.
Curtiss-Wright Corporation executive reports small stock sale under pre-set plan. EVP & Chief Growth Officer John C. Watts reported selling 288 shares of Curtiss-Wright common stock on January 8, 2026 at a price of $600 per share. After this transaction, he beneficially owns 3,188 shares directly. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 26, 2025 and was made in line with the company’s share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation executive John C. Watts reported a small planned stock sale. On 01/05/2026, he sold 107 shares of Curtiss-Wright common stock at a price of $578.84 per share. After this transaction, he beneficially owned 3,476 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Watts adopted on August 26, 2025 and was carried out by his financial advisor. The company notes that the shares were sold in line with its share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring additional common stock through deferred director compensation. On January 2, 2026, he acquired 727 shares of Curtiss-Wright common stock at a price of $572.38 per share, recorded as an acquisition. After this transaction, he beneficially owned 12,429 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation and receive annual restricted stock awards and fees in stock at a later date. The 727 shares relate to compensation earned in 2018, 2019, 2020, and 2021, with delivery deferred to January 2, 2026, and include dividend credits on outstanding awards.